1492 Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-501,050
| Closed | -$1.29M | – | 122 |
|
2022
Q3 | $1.29M | Buy |
501,050
+11,674
| +2% | +$30K | 0.93% | 37 |
|
2022
Q2 | $944K | Sell |
489,376
-20,452
| -4% | -$39.5K | 0.62% | 55 |
|
2022
Q1 | $1.51M | Buy |
509,828
+18,795
| +4% | +$55.8K | 0.8% | 44 |
|
2021
Q4 | $2.21M | Buy |
491,033
+2,724
| +0.6% | +$12.2K | 1.09% | 32 |
|
2021
Q3 | $2.37M | Buy |
488,309
+361,309
| +284% | +$1.76M | 1.2% | 30 |
|
2021
Q2 | $866K | Buy |
+127,000
| New | +$866K | 0.44% | 68 |
|